Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
KDMF
0
VMF
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
Annual Reports
NA
1. Dormicum
2. Hydrochloride, Midazolam
3. Maleate, Midazolam
4. Midazolam
5. Midazolam Maleate
6. Ro 21 3981
7. Ro 21-3981
8. Ro 213981
9. Versed
1. Midazolam Hcl
2. 59467-96-8
3. Versed
4. Hypnovel
5. Midazolam Hydrochloride [usan]
6. Ro 21-3981/003
7. Buccolam
8. Midazolam Hydrochloride Civ
9. Nsc-751451
10. W7ttw573jj
11. Shp615
12. Shp-615
13. 8-chloro-6-(2-fluorophenyl)-1-methyl-4h-imidazo[1,5-a][1,4]benzodiazepine Hydrochloride
14. 8-chloro-6-(2-fluorophenyl)-1-methyl-4h-imidazo[1,5-a][1,4]benzodiazepine;hydrochloride
15. Rocam
16. Ro-213981001
17. 8-chloro-6-(2-fluorophenyl)-1-methyl-4h-imidazo(1,5-a)(1,4)benzodiazepine Hydrochloride
18. Dsstox_cid_27824
19. Dsstox_rid_82587
20. Dsstox_gsid_47846
21. Midazolam Hydrochloride (usan)
22. Cas-59467-96-8
23. Ncgc00168254-01
24. Einecs 261-776-6
25. Unii-w7ttw573jj
26. Ro-21-3981/003
27. Versed Hydrochloride
28. Versed (tn)
29. Seizalam
30. Hypnovel Hydrochloride
31. Midazolam Hydrochloride Preservative Free
32. Midazolam (hydrochloride)
33. Schembl41265
34. Mls001401415
35. Chebi:6932
36. Chembl1200420
37. Dtxsid8047846
38. Hy-b0676a
39. Bcp15579
40. Midazolam Hydrochloride [mi]
41. Tox21_112613
42. Nsc751451
43. Midazolam Hydrochloride [hsdb]
44. Akos024457308
45. Tox21_112613_1
46. Ccg-100983
47. Midazolam Hydrochloride [mart.]
48. Midazolam Hydrochloride [vandf]
49. Nc00233
50. Nsc 751451
51. 4h-imidazo(1,5-a)(1,4)benzodiazepine, 8-chloro-6-(2-fluorophenyl)-1-methyl-, Hydrochloride
52. 8-chloro-6-(2-fluorophenyl)-1-methyl-4h-imidazo(1,5-a)(1,4)benzodiazepine Monohydrochloride
53. 8-chloro-6-(o-fluorophenyl)-1-methyl-4h-imidazo(1,5-a)(1,4)benzodiazepine Monohydrochloride
54. Midazolam Hydrochloride [who-dd]
55. Ncgc00168254-02
56. 4h-imidazo(1,5-a)(1,4)benzodiazepine, 8-chloro-6-(2-fluorophenyl)-1-methyl-, Monohydrochloride
57. Smr000469160
58. Midazolam Hydrochloride [orange Book]
59. Midazolam Hydrochloride Civ [usp-rs]
60. D00696
61. 467m968
62. Q27292444
63. 4h-imidazo[1,5a][1,4]benzodiazepine, 8-chloro-6-(2-fluorophenyl)-1-methyl-, Hydrochloride
Molecular Weight | 362.2 g/mol |
---|---|
Molecular Formula | C18H14Cl2FN3 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 3 |
Rotatable Bond Count | 1 |
Exact Mass | 361.0548810 g/mol |
Monoisotopic Mass | 361.0548810 g/mol |
Topological Polar Surface Area | 30.2 Ų |
Heavy Atom Count | 24 |
Formal Charge | 0 |
Complexity | 471 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 4 | |
---|---|
Drug Name | Midazolam hydrochloride |
Drug Label | Midazolam hydrochloride is a water-soluble benzodiazepine available as a sterile, nonpyrogenic parenteral dosage form for intravenous or intramuscular injection. Each mL contains midazolam hydrochloride equivalent to 1 mg or 5 mg midazolam USP compou... |
Active Ingredient | Midazolam hydrochloride |
Dosage Form | Syrup; Injectable |
Route | Injection; Oral |
Strength | eq 2mg base/ml; eq 1mg base/ml; eq 5mg base/ml |
Market Status | Prescription |
Company | Wockhardt; Ranbaxy; Bedford; Hospira; Gland Pharma; Roxane; Hi Tech Pharma; Paddock; Fresenius Kabi Usa; Hikma Maple; Bedford Labs; Akorn |
2 of 4 | |
---|---|
Drug Name | Midazolam hydrochloride preservative free |
Active Ingredient | Midazolam hydrochloride |
Dosage Form | Injectable |
Route | Injection |
Strength | eq 1mg base/ml; eq 5mg base/ml |
Market Status | Prescription |
Company | Sagent Strides; Hospira; Bd Rx |
3 of 4 | |
---|---|
Drug Name | Midazolam hydrochloride |
Drug Label | Midazolam hydrochloride is a water-soluble benzodiazepine available as a sterile, nonpyrogenic parenteral dosage form for intravenous or intramuscular injection. Each mL contains midazolam hydrochloride equivalent to 1 mg or 5 mg midazolam USP compou... |
Active Ingredient | Midazolam hydrochloride |
Dosage Form | Syrup; Injectable |
Route | Injection; Oral |
Strength | eq 2mg base/ml; eq 1mg base/ml; eq 5mg base/ml |
Market Status | Prescription |
Company | Wockhardt; Ranbaxy; Bedford; Hospira; Gland Pharma; Roxane; Hi Tech Pharma; Paddock; Fresenius Kabi Usa; Hikma Maple; Bedford Labs; Akorn |
4 of 4 | |
---|---|
Drug Name | Midazolam hydrochloride preservative free |
Active Ingredient | Midazolam hydrochloride |
Dosage Form | Injectable |
Route | Injection |
Strength | eq 1mg base/ml; eq 5mg base/ml |
Market Status | Prescription |
Company | Sagent Strides; Hospira; Bd Rx |
Treatment of prolonged, acute, convulsive seizures in infants, toddlers, children and adolescents (from three months to less than 18 years).
Buccolam must only be used by parents / carers where the patient has been diagnosed to have epilepsy.
For infants between three and six months of age, treatment should be in a hospital setting where monitoring is possible and resuscitation equipment is available.
Epileptic seizures
Adjuvants, Anesthesia
Agents that are administered in association with anesthetics to increase effectiveness, improve delivery, or decrease required dosage. (See all compounds classified as Adjuvants, Anesthesia.)
Anesthetics, Intravenous
Ultrashort-acting anesthetics that are used for induction. Loss of consciousness is rapid and induction is pleasant, but there is no muscle relaxation and reflexes frequently are not reduced adequately. Repeated administration results in accumulation and prolongs the recovery time. Since these agents have little if any analgesic activity, they are seldom used alone except in brief minor procedures. (From AMA Drug Evaluations Annual, 1994, p174) (See all compounds classified as Anesthetics, Intravenous.)
GABA Modulators
Substances that do not act as agonists or antagonists but do affect the GAMMA-AMINOBUTYRIC ACID receptor-ionophore complex. GABA-A receptors (RECEPTORS, GABA-A) appear to have at least three allosteric sites at which modulators act: a site at which BENZODIAZEPINES act by increasing the opening frequency of GAMMA-AMINOBUTYRIC ACID-activated chloride channels; a site at which BARBITURATES act to prolong the duration of channel opening; and a site at which some steroids may act. GENERAL ANESTHETICS probably act at least partly by potentiating GABAergic responses, but they are not included here. (See all compounds classified as GABA Modulators.)
Hypnotics and Sedatives
Drugs used to induce drowsiness or sleep or to reduce psychological excitement or anxiety. (See all compounds classified as Hypnotics and Sedatives.)
Anti-Anxiety Agents
Agents that alleviate ANXIETY, tension, and ANXIETY DISORDERS, promote sedation, and have a calming effect without affecting clarity of consciousness or neurologic conditions. ADRENERGIC BETA-ANTAGONISTS are commonly used in the symptomatic treatment of anxiety but are not included here. (See all compounds classified as Anti-Anxiety Agents.)
N05CD08
Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
Date of Issue : 2022-07-07
Valid Till : 2025-07-21
Written Confirmation Number : WC-0150
Address of the Firm :
NDC Package Code : 17511-134
Start Marketing Date : 2020-11-28
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (20mg/20mg)
Marketing Category : BULK INGREDIENT
Available Reg Filing : ASMF |
Supriya Lifesciences is a cGMP-compliant API manufacturing organization with a leadership position across key & niche products.
GDUFA
DMF Review : Reviewed
Rev. Date : 2018-06-29
Pay. Date : 2018-02-20
DMF Number : 25204
Submission : 2011-08-01
Status : Active
Type : II
NDC Package Code : 48087-0103
Start Marketing Date : 2012-06-29
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 39991
Submission : 2024-06-11
Status : Active
Type : II
NDC Package Code : 12828-0092
Start Marketing Date : 2021-10-18
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Date of Issue : 2022-06-08
Valid Till : 2025-06-25
Written Confirmation Number : WC-0107
Address of the Firm :
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 39991
Submission : 2024-06-11
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2018-06-29
Pay. Date : 2018-02-20
DMF Number : 25204
Submission : 2011-08-01
Status : Active
Type : II
Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
Date of Issue : 2022-07-07
Valid Till : 2025-07-21
Written Confirmation Number : WC-0150
Address of the Firm : R. S. No. 50/1, Mukteswarapuram (V), Jaggalahpet (M), Krishna -District- 521175,...
Date of Issue : 2022-06-08
Valid Till : 2025-06-25
Written Confirmation Number : WC-0107
Address of the Firm : Plot No. 75/76, Chikhloli, MIDC, Ambernath (W), Dist- Thane
Date of Issue : 2019-10-07
Valid Till : 2022-07-02
Written Confirmation Number : WC-0101
Address of the Firm : 21-M Attibele Industrial Area, Anekal Taluk, Bangalore-562107
Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
NDC Package Code : 17511-134
Start Marketing Date : 2020-11-28
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (20mg/20mg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 12828-0092
Start Marketing Date : 2021-10-18
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 48087-0103
Start Marketing Date : 2012-06-29
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
About the Company : Cohance Lifesciences is a leading CDMO and API platform, offering products and services across all phases of a molecule’s lifecycle from development to commercialzation. With our...
About the Company : Jai Radhe Sales was founded in 1999 as an out-of-the-box distribution firm specializing in the global supply of high-quality pharmaceutical ingredients. The firm provides complete ...
About the Company : Nortec Química stands as the largest manufacturer of Active Pharmaceutical Ingredients (IFAs) in Latin America, embarking on its mission to ensure the availability of quality medi...
Supriya Lifesciences is a cGMP-compliant API manufacturing organization with a leadership position across key & niche products.
About the Company : Supriya Lifescience Ltd. specializes in API manufacturing, focusing on therapeutic segments like antihistamines, anti-allergic drugs, vitamins, anaesthetics and anti-asthmatics. Su...
About the Company : Centaur accepts change as a constant, and continuously innovates to remain significant. Centaur has built knowledge sharing relationships with the pharmaceutical majors in areas of...
About the Company : Formil QuImica Ltd is a Brazilian company located in BaruerI - SP. We produce through chemical synthesis or extraction and commercialize API (Active Pharmaceutical Ingredient) on l...
About the Company : Fuan Pharmaceutical (Group) Co., Ltd. was established on February 25, 2004. The company is located in Chongqing Changshou Economic and Technological Development Zone, covering an a...
About the Company : Lake Chemicals is specialized in Benzodiazepine and CNS range of products such as Alprazolam, Bromazepam, Clobazam, Clonazepam, Midazolam Salts, Lorazepam, Olanzapine Form-1 etc. H...
About the Company : Indian Pharmaceutical Company, Precise Group is emerging as a global player in several verticals in healthcare. The Mumbai based drug manufacturing company’s strength lies in a s...
About the Company : Indian Pharmaceutical Company, Precise Group is emerging as a global player in several verticals in healthcare. The Mumbai based drug manufacturing company’s strength lies in a s...
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Regulatory Info :
Registration Country : Sweden
Brand Name : Midazolam Accord
Dosage Form : INJEKTIONS-/INFUSIONSVÄTSKA, LÖSNING
Dosage Strength : 1 MG/ML
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Sweden
Regulatory Info :
Registration Country : Sweden
Brand Name : Dormicum
Dosage Form : SOLUTION FOR INJECTION
Dosage Strength : 5 MG / ML
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Sweden
Regulatory Info :
Registration Country : Sweden
Brand Name : Midazolam Hameln
Dosage Form : INJEKTIONSVÄTSKA, LÖSNING
Dosage Strength : 5 MG/ML
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Sweden
Regulatory Info :
Registration Country : Norway
Brand Name : Midazolam hamel
Dosage Form : Solution for injection/infusion
Dosage Strength : 5 mg/ml
Packaging : ampoule 5 10ml
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info :
Registration Country : Norway
Brand Name : Midazolam hamel
Dosage Form : Solution for injection/infusion
Dosage Strength : 1mg/ml
Packaging : Vials 1 50ml
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Regulatory Info :
Registration Country : Switzerland
Brand Name : Buccolam
Dosage Form : Solution
Dosage Strength : 10mg/2ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Switzerland
Regulatory Info :
Registration Country : Switzerland
Brand Name : Buccolam
Dosage Form : Solution
Dosage Strength : 7.5mg/1.5ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Switzerland
Regulatory Info :
Registration Country : Sweden
Brand Name : BUCCOLAM
Dosage Form : MUNHÅLELÖSNING
Dosage Strength : 2.5 MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Sweden
Regulatory Info :
Registration Country : Sweden
Brand Name : BUCCOLAM
Dosage Form : MUNHÅLELÖSNING
Dosage Strength : 5 MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Sweden
Regulatory Info :
Registration Country : Switzerland
Brand Name : Dormicum
Dosage Form : Filmtabl
Dosage Strength : 15mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Switzerland
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
Patents & EXCLUSIVITIES
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?